期刊文献+

HPLC-UV-MS方法对治疗糖尿病药品或保健品中可能非法添加的4种α-葡糖苷酶抑制剂成分的定性与定量分析(英文) 被引量:6

Development and validation of HPLC-UV-MS method for the control of four anti-diabetic drugs in suspected counterfeit products
原文传递
导出
摘要 本文建立了一种反相高效液相色谱-紫外光谱检测法,可同时定量检测维力波糖、米格列醇、维格列波糖和阿卡波糖这4种α-葡糖苷酶抑制剂。采用Prevail carbohydrate(250mm×4.6mm,5μm)色谱柱,以乙腈-磷酸盐缓冲液(pH8.0)进行梯度洗脱,在210nm下进行检测,结果维力波糖、米格列醇、维格列波糖和阿卡波糖的线性范围分别为58.2~932.0μg·mL-1(r=0.9999,n=5)、23.5~376.0μg·mL-1(r=0.9999,n=5)、0.128~2.050mg·mL-1(r=0.9999,n=5)、38.2~612.0μg·mL-1(r=0.9999,n=5);平均回收率分别为97.0%、103.6%、96.4%和100.4%(n=9)。与此同时,本文还建立高相液相色谱-质谱检测方法,用于这4种化合物的定性分析。以上两种方法简便快捷,结果准确可靠、重复性好,可用于可疑的糖尿病药品中非法添加α-葡糖苷酶抑制剂的定性定量检测。 An HPLC-UV method has been developed for the determination of valibose, miglitol, voglibose and acarbose, the four anti-diabetic drugs. The separation was accomplished successfully by using reversed phase chromatography (Prevail carbohydrate column, 250 mm × 4.6 mm, 5 μm) with a gradient acetonitrile-phosphate buffer solution (pH 8.0) at a wavelength of 210 nm. Furthermore, the method of a high-performance liquid chromatography coupled with ESI-MS in positive ionization mode has been established. These two methods were successfully applied to the assay and qualitative detection of four α-glucosidase inhibitors in the potential counterfeit anti-diabetic drugs.
出处 《药学学报》 CAS CSCD 北大核心 2010年第3期347-352,共6页 Acta Pharmaceutica Sinica
关键词 降糖药 α-葡糖苷酶抑制剂 非法添加药物 HPLC-UV UPLC-ESI-MS anti-diabetic drug α-glucosidases inhibitor counterfeit drug HPLC-UV UPLC-ESI-MS
  • 相关文献

参考文献2

二级参考文献10

共引文献16

同被引文献205

引证文献6

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部